Uterine fibroids  are common, noncancerous growths that develop in or around the uterus. Their prevalence varies depending on factors such as age and the method used to detect them. Some uterine fibroids cause no symptoms, while others may be associated with heavy menstrual bleeding, pelvic pressure, frequent urination or pelvic discomfort. Symptoms vary according to the size, number and location of the fibroids. Treatment options for symptomatic uterine fibroids include medication, minimally invasive procedures and surgery. The appropriate approach depends on symptom severity, fibroid characteristics, overall health and future pregnancy plans.
Hysterectomy is one treatment option for uterine fibroids, but it is not the only option. Depending on the patient's clinical findings and treatment goals, alternatives may include medication, myomectomy or uterine fibroid embolization (UFE).
Hysterectomy permanently removes the uterus and ends the possibility of carrying a pregnancy. Recovery depends on the surgical approach and individual circumstances. If the ovaries are removed during surgery, menopause occurs; if they are retained, menopause does not necessarily occur immediately. Patients should discuss the potential benefits, risks and long-term implications with their gynaecologist.
Several treatment approaches are available for uterine fibroids, including uterine fibroid embolization. A specialist can explain the potential benefits, limitations and risks of each option based on individual clinical findings.
Uterine Fibroid Embolization: Procedure, Benefits and Considerations
During uterine fibroid embolization (UFE), an interventional radiologist inserts a thin catheter into an artery, commonly through the groin or wrist, and guides it using imaging. Small embolic particles are delivered into selected uterine arteries to reduce the blood supply to the fibroids. The treated fibroids generally shrink over time, and symptoms may improve. The procedure, recovery and outcomes vary between patients.
Uterine fibroid embolization may reduce fibroid-related symptoms, including heavy menstrual bleeding and pelvic pressure, in appropriately selected patients. The degree of symptom improvement and fibroid shrinkage varies. Any numerical success-rate claim should be supported by reliable clinical evidence that clearly defines the outcome measured, patient population and follow-up period.For patients whose heavy menstrual bleeding is caused by fibroids, UFE may reduce bleeding over time. Embolization reduces the blood supply to the treated fibroids, which can lead to shrinkage. The response varies, and follow-up is important to assess treatment outcomes and any continuing symptoms.
Fibroid embolization is a negligibly intrusive treatment that doesn’t need a medical procedure, diminishing hospital stay and recuperation time.

| Appoinment: |Call +91-7032508468| Whatsapp:+91-7337583901